Pliant Therapeutics, Inc.PLRXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-128.71M
↓ 73% vs avg
Percentile
P13
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-74.51M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-128.71M | +19.2% |
| 2024 | $-159.35M | -35.9% |
| 2023 | $-117.28M | -21.7% |
| 2022 | $-96.39M | -24.5% |
| 2021 | $-77.40M | -99.5% |
| 2020 | $-38.80M | -944.8% |
| 2019 | $-3.71M | +87.9% |
| 2018 | $-30.65M | -67.2% |
| 2017 | $-18.33M | - |